Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s Why

Terumo Corp. (OTCMKTS:TRUMY) gapped down prior to trading on Friday . The stock had previously closed at $12.76, but opened at $12.1501. Terumo shares last traded at $12.54, with a volume of 652 shares traded.

Terumo Price Performance

The stock has a market capitalization of $18.63 billion, a PE ratio of 21.78 and a beta of 0.74. The company has a quick ratio of 1.46, a current ratio of 2.51 and a debt-to-equity ratio of 0.07. The stock’s 50-day moving average is $14.00 and its 200 day moving average is $15.80.

Terumo (OTCMKTS:TRUMY) last released its earnings results on Friday, February 13th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The company had revenue of $1.94 billion during the quarter, compared to analysts’ expectations of $1.82 billion. Terumo had a return on equity of 9.13% and a net margin of 11.74%.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.